Listar por autor "Moya-García, Aurelio Ángel"
Mostrando ítems 1-5 de 5
-
A course-based undergraduate research experience to illustrate the early stages of the drug discovery process
García-Caballero, Melissa; Moya-García, Aurelio Ángel
; Torres-Vargas, José Antonio; García-Ponce, Ángel Luis; Rodríguez-Quesada, Ana María (Wiley, 2022-07-12)
We have implemented at the University of Málaga (Spain) a new course-based undergraduate research experience (CURE) to involve undergraduate students of Science in a real-world scientific problem. Within the topic “Let's ... -
Deciphering breast cancer intertumor heterogeneity: tumor subtyping and analysis of germline genetic variants
(UMA Editorial, 2018-07)INTRODUCCIÓN: El cáncer de mama no es una única enfermedad, sino un conjunto de enfermedades que presentan una gran variabilidad en todos sus componentes: características histopatológicas, respuesta al tratamiento y ... -
KinFams: De-Novo Classification of Protein Kinases Using CATH Functional Units
Adeyelu, Tolulope; Bordin, Nicola; Waman, Vaishali P.; Sadlej, Marta; Sillitoe, Ian; Moya-García, Aurelio Ángel; Orengo, Christine A.[et al.] (IOAP-MDPI, 2023-02-02)
Protein kinases are important targets for treating human disorders, and they are the second most targeted families after G-protein coupled receptors. Several resources provide classification of kinases into evolutionary ... -
Network perspective of histamine related diseases
Moya-García, Aurelio Ángel; Rodríguez-López, Rocío; Medina-Torres, Miguel Ángel; Sánchez-Jiménez, Francisca María (2017-08-29)
Histamine is the most pleiotropic biogenic amine. Produced and stored by a limited set of cells—histaminergic neurons, enterochromaffin-like cells, and mast cells—it broadcasts intercellular communication signals to a wide ... -
Protein Functional Families to characterise drug-target interactions.
Moya-García, Aurelio Ángel (Proceedings IWBBIO 2017, 2017)
The quest for “magic bullets” has been the driving force in drug discovery during the last two decades. However, the increasing rate of drug failure over this period has occurred concurrently with the assumption that a ...